IHC Marker - Lambda Light Chain Test: Booking, Price, and Results
About IHC Marker - Lambda Light Chain Test
| Field | Value |
|---|---|
| Also Known As | Lambda Light Chain IHC Test, Lambda Immunostain Test, Ig Lambda Light Chain Immunohistochemistry Test |
| Sample Type | Formalin-fixed, paraffin-embedded (FFPE) tissue block |
| Fasting Required | Not required |
| Report Time | 7 days |
| Recommended For | All genders and ages; typically ordered when a plasma cell neoplasm or B-cell lymphoma is suspected |
| Price | Starting at ₹1,920 |
What Is an IHC Marker - Lambda Light Chain Test?
The IHC marker - lambda light chain test is a specialised pathology test that detects lambda light chain proteins in a tissue sample. It uses a laboratory technique called immunohistochemistry (IHC), which applies antibodies to tissue sections to reveal specific proteins. Doctors order this test when they suspect certain blood cancers, such as lymphoma or multiple myeloma. The test is also known as the lambda light chain IHC test, lambda immunostain test, or Ig lambda light chain immunohistochemistry test.
What Does an IHC Marker - Lambda Light Chain Test Measure?
This test measures the presence and distribution of lambda light chain proteins within cells in a tissue sample. Here is what that indicates:
| Component | What It Is | Why It Matters |
|---|---|---|
| Lambda Light Chain | One of two types of immunoglobulin (antibody) protein chains found in B lymphocytes and plasma cells | Helps identify whether cells are producing only one type of light chain, which may signal malignancy |
Why Is an IHC Marker - Lambda Light Chain Test Done?
Doctors order this test when tissue from a biopsy needs to be examined for signs of a clonal or malignant cell population. Below are the common reasons this test is requested.
Common Symptoms That May Require This Test
The following symptoms may prompt a doctor to investigate further and order this test:
- Swollen lymph nodes that persist without an obvious cause
- Unexplained fatigue and weakness
- Persistent fever and drenching night sweats
- Unintended weight loss
- Bone pain or unexplained fractures
- Anaemia detected on a blood test
- Unexplained lumps or masses in the body
Conditions This Test Can Help Detect
A doctor uses this test to help identify a range of haematological conditions, including:
- Multiple myeloma and other plasma cell neoplasms
- Monoclonal gammopathy of undetermined significance (MGUS)
- Plasmacytoma (a localised tumour of plasma cells)
- Non-Hodgkin lymphomas, including cutaneous B-cell lymphomas
- Leukaemias with abnormal lymphoid populations
- Lambda-type AL amyloidosis (a condition where abnormal light chain proteins deposit in organs)
How to Prepare and What to Expect
Since this test is performed on a tissue sample rather than a blood draw, the preparation steps differ from routine blood tests.
Do You Need to Fast?
No fasting is required. This test uses a tissue block from a previous biopsy or surgical procedure, so there is no need to avoid food or drink beforehand. Always follow the specific instructions provided by your doctor.
Practical Tips Before Your Test
The following steps will help ensure the process goes smoothly:
- Bring a detailed clinical history including your symptoms, previous test results, and family history, as this is required for the test
- Bring the original histopathology report from the biopsy along with any relevant imaging reports
- Coordinate with your oncologist or haematologist before submitting the sample
Step-by-Step Procedure
The IHC marker – lambda light chain test procedure involves the following steps:
- A tissue sample is collected during a biopsy or surgical procedure and immediately placed in formalin to preserve its proteins and cellular structures.
- The tissue is then embedded in a paraffin wax block, known as an FFPE (formalin-fixed, paraffin-embedded) block, which can be stored and transported at room temperature.
- At the laboratory, very thin slices of the tissue block are cut and placed on glass slides.
- A specialised antibody targeting the lambda light chain protein is applied to the slide. A coloured marker (chromogen) makes the staining visible under a microscope.
- A qualified pathologist examines the stained slides and assesses the pattern of lambda light chain expression across the cells.
- The findings are documented in a report, which is sent to your treating doctor within 7 days.
Factors That Can Affect Accuracy
Several factors can influence the quality of the test result:
- Inadequate or delayed fixation of the tissue sample after removal
- Prolonged time between tissue removal and placing it in formalin (ischaemic time), which can cause cellular degradation
- Poor tissue processing or low-quality paraffin embedding
- Coexisting reactive or inflammatory cells in the same tissue area
Understanding Your IHC Marker - Lambda Light Chain Test Results
Results from this test must be reviewed by a pathologist alongside clinical information and other relevant tests. The table below explains what different staining patterns may indicate:
| Finding | Interpretation |
|---|---|
| Polyclonal staining (mixed kappa and lambda) | Suggests reactive or benign lymphoid tissue |
| Normal kappa:lambda ratio (approximately 2:1 to 3:1) | Consistent with normal immune tissue |
| Lambda restriction (predominant lambda staining) | Suggests a clonal, potentially malignant cell population |
| Abnormal ratio (kappa:lambda greater than 4:1 or less than 1:2) | Indicates clonality; supports a diagnosis of plasma cell neoplasm or lymphoma |
These ranges are general guidelines. Your doctor will interpret your results based on your age, health history, and other factors. Always consult a qualified healthcare professional for personalised medical advice.
Results During Special Conditions
Certain situations may affect how results are interpreted:
- In rare cases, plasma cells in a biopsy may appear to express both light chains (polytypic pattern) by IHC. In an appropriate clinical setting, this does not always exclude a plasma cell neoplasm; additional investigations may be needed.
- Background reactive or inflammatory plasma cells can coexist with neoplastic cells in the same tissue, which may make interpretation more challenging.
How to Maintain Healthy Levels
Lambda light chain expression in tissue reflects underlying disease biology and is not directly influenced by lifestyle. The following general steps support overall health during investigation and follow-up:
- Follow your doctor's guidance on further diagnostic workup or treatment
- Attend all follow-up appointments if you are being monitored for a suspected or confirmed plasma cell disorder
- Share all relevant medical records with your treating team to support accurate interpretation of results
Lupin Diagnostics IHC Marker - Lambda Light Chain Test Price
The IHC marker – lambda light chain test cost at Lupin Diagnostics starts at ₹1,920. This test requires a visit to a hospital; home collection is not available as the test requires submission of an FFPE tissue block. The table below shows indicative prices across major cities:
| City | Approximate Price (₹) |
|---|---|
| BHOPAL | 1920 |
| CHENNAI | 1920 |
| HYDERABAD | 1920 |
| KOLKATA | 1920 |
| NAVI MUMBAI | 1920 |
| PUNE | 1920 |
Prices are indicative and may vary by location. Please confirm the current price at the time of booking.
How to Book
Follow these steps for IHC marker - lambda light chain test online booking:
- Select the test on the Lupin Diagnostics website.
- Choose your city and preferred centre location.
- Visit the centre at your scheduled time to submit your FFPE tissue block or unstained slides.
- Receive your report via email or WhatsApp within the stipulated turnaround time.
Frequently Asked Questions
This test detects whether the lymphoid or plasma cells in a tissue sample are producing only lambda light chains, which would indicate a clonal and potentially malignant cell population. It is used to help diagnose conditions such as B-cell lymphomas, multiple myeloma, plasmacytoma, and related plasma cell disorders.
Both tests are typically ordered together to calculate the kappa-to-lambda ratio in the tissue. Normal tissue contains a balanced mixture of both types. When one type dominates significantly, it points to a clonal cell population, which is a key indicator of malignancy.
Lambda restriction means the tissue cells are predominantly producing lambda light chains rather than a normal mixture. This points to a clonal cell population, which supports a diagnosis of a lymphoid or plasma cell malignancy such as lymphoma or myeloma. Your doctor will confirm the diagnosis with additional tests and clinical assessment.
No. This test is one part of a larger diagnostic picture. A pathologist interprets the result alongside other IHC markers, imaging findings, clinical history, and sometimes molecular or genetic tests before a final diagnosis is made.
Home collection is not available for this test. Because the sample is an FFPE tissue block from a biopsy, it must be submitted directly to a Lupin Diagnostics centre. Please carry your biopsy block and all relevant clinical documents when you visit.
At Lupin Diagnostics, the report is typically delivered within 7 days of the laboratory receiving the tissue sample. You will receive your results digitally via email or WhatsApp. Your treating doctor will discuss the findings with you in the context of your overall clinical evaluation.
IHC Marker - Lambda Light Chain Test: Booking, Price, and Results
